← Eichor
Condition: Myocardial Viability Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Myocardial Viability

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Prognostic Value of Hyperpolarized 13C MRI for Clinical Myocardial Viability
Phase N/A · 1 location(s) · University of Texas Southwestern Medical Center · NCT06047028
Hyperpolarized 13C Pyruvate-MRI and FDG-PET in a Single Exam for the Prognosis of Ischemic Cardiomyopathy
Phase N/A · 1 location(s) · University of Texas Southwestern Medical Center · NCT06814587
PET Myocardial Fatty-acid Metabolic Imaging With XTR003 Injection and 18F-FDG to Assess Myocardial Viability in Ischemic
Phase 2 · 3 location(s) · Sinotau Pharmaceutical Group · NCT07443696
A Clinical Study of Evaluating Myocardial Viability in Ischemic Heart Disease with Integrated 18F-FDG PET/MR
Phase N/A · 1 location(s) · Shanghai East Hospital · NCT06712862
Subendocardial Viability Ratio in Hypertension
Phase N/A · 5 location(s) · Istituto Auxologico Italiano · NCT06309511
Impact of Del Nido Versus Blood Cardioplegia on Myocardial Viability Assessed With Magnetic Resonance Imaging
NA · 2 location(s) · Klinički Bolnički Centar Zagreb · NCT07637266
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.